Pudexacianinium

N/A

Report date: 2026/02/11 20:01:36
NME

Base Information

Drug NamePudexacianinium
Drug Alias Name普地沙铵ASP-5354
ClassificationSmall moleculesDiagnostic agent (In vivo)
Mechanisms of ActionDiagnostic imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsContrast agentsUreteral DiseasesBreast Neoplasms +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsContrast agentsUreteral Diseases
Inactive IndicationsBreast NeoplasmsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A